Showing results (81-90 of 173) with videos related to
Sort By:
Pageof 18
Scientific Reports|January 14, 2018
High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemiaElisabeth M P Steeghs, Marjolein Bakker, Alex Q Hoogkamer, et al.Leukemia|June 6, 2024
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?Anna Østergaard, Marta Fiocco, Hester de Groot-Kruseman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2013
Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk groupCornelia Eckert, Günter Henze, Karlheinz Seeger, et al.Journal of Adolescent and Young Adult Oncology|December 17, 2016
Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and HematologyGabriele Escherich, Stefan Bielack, Stephan Maier, et al.Blood Advances|February 22, 2024
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutationsInge van Outersterp, Judith M Boer, Cesca van de Ven, et al.International Journal of Cancer|November 24, 2017
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100Carmela De Santo, Sarah Booth, Ashley Vardon, et al.Pediatric Blood & Cancer|September 21, 2022
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialKerstin Mezger, Sabine Ebert, Hannah Elisa Muhle, et al.The Lancet. Oncology|August 18, 2012
Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup studyAndrea Biondi, Martin Schrappe, Paola De Lorenzo, et al.Journal of Hematology & Oncology|May 30, 2015
Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemiaAnna Wojtuszkiewicz, Godefridus J Peters, Nicole L van Woerden, et al.Haematologica|March 7, 2020
Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemiaYuzhe Shi, Melanie C Beckett, Helen J Blair, et al.Pageof 18